ALEXION PHARMACEUTICALS, INC. Insider Trading for December 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALEXION PHARMACEUTICALS, INC. for December 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 21 2020 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Option Exercise | M | 140.16 | 11,000 | 1,541,760 | 0 | |
| Dec 21 2020 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Option Exercise | M | 97.58 | 13,066 | 1,274,980 | 0 | |
| Dec 21 2020 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Sell | S | 158.00 | 1,100 | 173,800 | 30,883 | 32 K to 30.9 K (-3.44 %) |
| Dec 21 2020 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Sell | S | 157.76 | 13,066 | 2,061,292 | 31,983 | 45 K to 32 K (-29.00 %) |
| Dec 21 2020 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Sell | S | 157.59 | 9,900 | 1,560,141 | 45,049 | 54.9 K to 45 K (-18.02 %) |
| Dec 21 2020 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Buy | M | 140.16 | 11,000 | 1,541,760 | 54,949 | 43.9 K to 54.9 K (+25.03 %) |
| Dec 21 2020 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Buy | M | 97.58 | 13,066 | 1,274,980 | 43,949 | 30.9 K to 43.9 K (+42.31 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Payment of Exercise | F | 157.96 | 13,059 | 2,062,800 | 267,773 | 280.8 K to 267.8 K (-4.65 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Payment of Exercise | F | 157.96 | 72,533 | 11,457,313 | 280,832 | 353.4 K to 280.8 K (-20.53 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Grant | A | 0.00 | 162,707 | 0 | 353,365 | 190.7 K to 353.4 K (+85.34 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Payment of Exercise | F | 157.96 | 1,725 | 272,481 | 30,883 | 32.6 K to 30.9 K (-5.29 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Payment of Exercise | F | 157.96 | 7,087 | 1,119,463 | 32,608 | 39.7 K to 32.6 K (-17.85 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Grant | A | 0.00 | 15,371 | 0 | 39,695 | 24.3 K to 39.7 K (+63.19 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Payment of Exercise | F | 157.96 | 3,261 | 515,108 | 67,301 | 70.6 K to 67.3 K (-4.62 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Payment of Exercise | F | 157.96 | 18,134 | 2,864,447 | 70,562 | 88.7 K to 70.6 K (-20.45 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Grant | A | 0.00 | 40,677 | 0 | 88,696 | 48 K to 88.7 K (+84.71 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | Franchini Indrani Lall | EVP, Chief Complian ... | Payment of Exercise | F | 157.96 | 2,913 | 460,137 | 46,345 | 49.3 K to 46.3 K (-5.91 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | Franchini Indrani Lall | EVP, Chief Complian ... | Payment of Exercise | F | 157.96 | 16,925 | 2,673,473 | 49,258 | 66.2 K to 49.3 K (-25.57 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | Franchini Indrani Lall | EVP, Chief Complian ... | Grant | A | 0.00 | 37,965 | 0 | 66,183 | 28.2 K to 66.2 K (+134.54 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | ORLOFF JOHN J | EVP, Research & Dev ... | Grant | A | 93.53 | 40 | 3,741 | 63,851 | 63.8 K to 63.9 K (+0.06 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | ORLOFF JOHN J | EVP, Research & Dev ... | Payment of Exercise | F | 157.96 | 3,261 | 515,108 | 63,811 | 67.1 K to 63.8 K (-4.86 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | ORLOFF JOHN J | EVP, Research & Dev ... | Payment of Exercise | F | 157.96 | 18,134 | 2,864,447 | 67,072 | 85.2 K to 67.1 K (-21.28 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | ORLOFF JOHN J | EVP, Research & Dev ... | Grant | A | 0.00 | 40,677 | 0 | 85,206 | 44.5 K to 85.2 K (+91.35 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | EVP, CFO | Payment of Exercise | F | 157.96 | 2,510 | 396,480 | 39,467 | 42 K to 39.5 K (-5.98 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | EVP, CFO | Payment of Exercise | F | 157.96 | 6,853 | 1,082,500 | 41,977 | 48.8 K to 42 K (-14.03 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | EVP, CFO | Grant | A | 0.00 | 15,371 | 0 | 48,830 | 33.5 K to 48.8 K (+45.94 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | Chiniara Ellen | EVP & Chief Legal O ... | Grant | A | 95.53 | 56 | 5,350 | 43,060 | 43 K to 43.1 K (+0.13 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | Chiniara Ellen | EVP & Chief Legal O ... | Payment of Exercise | F | 157.96 | 2,988 | 471,984 | 43,004 | 46 K to 43 K (-6.50 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | Chiniara Ellen | EVP & Chief Legal O ... | Payment of Exercise | F | 157.96 | 16,925 | 2,673,473 | 45,992 | 62.9 K to 46 K (-26.90 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | Chiniara Ellen | EVP & Chief Legal O ... | Grant | A | 0.00 | 37,965 | 0 | 62,917 | 25 K to 62.9 K (+152.15 %) |
| Dec 04 2020 | ALXN | ALEXION PHARMACEUT ... | Carino Tanisha | EVP & CCAO | Sell | S | 122.26 | 1,530 | 187,058 | 16,102 | 17.6 K to 16.1 K (-8.68 %) |
| Dec 04 2020 | ALXN | ALEXION PHARMACEUT ... | Carino Tanisha | EVP & CCAO | Sell | S | 122.26 | 1,530 | 187,058 | 16,102 | 17.6 K to 16.1 K (-8.68 %) |
| Dec 04 2020 | ALXN | ALEXION PHARMACEUT ... | Carino Tanisha | EVP & CCAO | Payment of Exercise | F | 121.76 | 665 | 80,970 | 17,632 | 18.3 K to 17.6 K (-3.63 %) |
| Dec 04 2020 | ALXN | ALEXION PHARMACEUT ... | Carino Tanisha | EVP & CCAO | Payment of Exercise | F | 121.76 | 665 | 80,970 | 17,632 | 18.3 K to 17.6 K (-3.63 %) |
| Dec 01 2020 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | EVP, CFO | Payment of Exercise | F | 124.00 | 1,298 | 160,952 | 33,459 | 34.8 K to 33.5 K (-3.73 %) |